Healthcare -
Biotechnology - NASDAQ - US
$ 36.82
0.766 %
$ 2.19 B
Market Cap
13.44
P/E
PTGX - OPERATING INCOME
Operating Income PTGX - Protagonist Therapeutics, Inc.
-93.7 M
LAST VALUE
13.73%
2 YEAR CAGR
-17.25%
5 YEAR CAGR
0.00%
10 YEAR CAGR